🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Noura Radwan

University of Maryland, Baltimore

ORCID: 0000-0002-3511-0125

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)”.

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

BMC Cancer(2020)10.1186/s12885-020-07000-2

N/A

1.1DataRank · unranked

32 citations

Matthew P. Deek, Ryan Phillips, Robert F. Hobbs, Reem Malek, Noura Radwan +26 more

Prognostic impact of circulating tumor cells in oligometastatic hormone-sensitive prostate cancer following metastasis-directed therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.199

N/A

0DataRank · unranked

1 citations

Philip Sutera, Ryan Phillips, Mathew Pierre Deek, Noura Radwan, Catherine H. Marshall +15 more

Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer

Advances in Radiation Oncology(2024)10.1016/j.adro.2024.101507

N/A

0DataRank · unranked

7 citations

Matthew P. Deek, Rebecca A. Deek, Ozan Cem Güler, Pervin Hürmüz, Mehmet Reyhan +22 more